Ensign Group Inc(ENSG) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | 27.72 | EPS (ttm) | 6.38 | Insider Own | 3.6% | Shs Outstand | 58.3M | Perf Week | 2.24% |
| Market Cap | 10.31B | Forward P/E | 20.61 | EPS next Y | 9.9% | Insider Trans | -0.11% | Shs Float | 56.2M | Perf Month | 0.99% |
| Enterprise Value | 12.24B | PEG | 1.62 | EPS next Q | 1.97 | Inst Own | 91.35% | Short Float | 2.63% | Perf Quarter | -3.4% |
| Income | 0.38B | P/S | 1.88 | EPS this Y | 18.9% | Inst Trans | -2.88% | Short Ratio | 4.23 | Perf Half Y | -6.85% |
| Sales | 5.49B | P/B | 4.22 | EPS next 5Y | 12.74% | ROA | 7.09% | Short Interest | 1.48M | Perf YTD | 1.56% |
| Book/sh | 41.9 | P/C | 32.14 | EPS past 3/5Y | 13.93% 13.84% | ROE | 16.98% | 52W High | -18.84% ($218.00) | Perf Year | -4.91% |
| Cash/sh | 5.51 | P/FCF | 24.6 | Sales past 3/5Y | 19.77% 16.5% | ROIC | 8.29% | 52W Low | 24.96% ($141.58) | Perf 3Y | 85.55% |
| Dividend Est. | $0.27 (0.15%) | EV/EBITDA | 20.53 | EPS Y/Y TTM | 15.48% | Gross Margin | 13.96% | Volatility(W/M) | 2.39% 2.13% | Perf 5Y | 151.59% |
| Dividend TTM | 0.26 | EV/Sales | 2.23 | Sales Y/Y TTM | 18.89% | Oper. Margin | 8.78% | ATR (14) | 3.91 | Perf 10Y | 886.37% |
| Dividend Ex-Date | 2026/9/30 | Quick Ratio | 1.21 | EPS Q/Q | 16.43% | Profit Margin | 6.9% | RSI (14) | 53.96 | Recom | 1.43 |
| Dividend Gr. 3/5Y | 4.35% 4.56% | Current Ratio | 1.21 | Sales Q/Q | 17.33% | SMA20 | 1.75% ($173.88) | Beta | 0.66 | Target Price | $220 |
| Payout | 4.32% | Debt/Eq | 0.92 | Earnings | 2026/7/27 | SMA50 | 1.16% ($174.89) | Rel Volume | 1.39 | Prev Close | $175.59 |
| Employees | 46000 | LT Debt/Eq | 0.87 | EPS/Sales Surpr. | 3.91% -0.08% | SMA200 | -2.56% ($181.57) | Avg Volume(3M) | 0.35M | Price | $176.92 |
| IPO | 2007/11/9 | Option/Short | Yes/Yes | Trades | 11509 | Volume | 484,746 | Change | 0.76% |
A US healthcare company that operates skilled nursing facilities and rehabilitation and senior care facilities, making it a long-term and post-acute care provider whose performance is driven by aging-related demand and expansion through acquisitions.
Over the past 1 year, roughly in the middle
19% below its 1-year high.
Traded more than usual. That is 139% of its average volume.
ENSG makes money exceptionally well
Of every $100 in sales, $8.78 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +18.9% this year.
Tap to view numbers
The price is about the industry average
For a company earning $100 a year, you would pay $2,772. Peers typically go for $2,171. It is about in line with its own 5-year average.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have paid off
Bought 5 years ago, your return today would be +151.6%. The S&P 500 did +68% over the same period.
Tap to view numbers
The dividend is on the small side
Pays 0.15% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 91.3%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
It ranks #7 of 48 in the industry
Based on market cap of $10B.
FAQ
What kind of company is ENSG?
ENSG belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is the market cap of ENSG?
The market cap of ENSG is approximately $10.3B, ranking 892 within its sector.
Does ENSG pay dividends?
ENSG has a dividend yield of approximately 0.15%, with an annual dividend of $0.27.
What is the P/E ratio of ENSG?
ENSG has a P/E ratio of approximately 27.7x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for ENSG?
ENSG has recorded a 52-week high of $218.00 and a low of $141.58.